Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $49.46 USD
Change Today +2.25 / 4.77%
Volume 768.1K
As of 1:42 PM 06/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas D. Reed Ph.D.

Founder and Chief Science Officer, Intrexon Corporation
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

48--

Background*

Dr. Thomas D. Reed, Ph.D., Co-founded Intrexon Corporation in 1998 and has been its Chief Science Officer since 1998. Dr. Reed served as Head of Consumer Sector at Intrexon Corporation. He is a molecular geneticist with over twenty years of experience in recombinant DNA technology. He has developed sophisticated transgenic model systems for studying the role of gene products in neuronal, cardiovascular, and cancer systems. He served as Chairman of Intrexon Corporation. ...

Read Full Background

Corporate Headquarters*

20374 Seneca Meadows Parkway
Germantown, Maryland 20876

United States

Phone: 301-556-9900
Fax: --

Board Members Memberships*

1998-2014
Founder and Chief Science Officer

Education*

PhD
University of Cincinnati
BS
University of California, Davis
MS
Wright State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XON:US $49.48 USD +2.27

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John W. Varian Chief Executive Officer and Director
XOMA Corporation
$569.5K
Simon E. Moroney Ph.D.Chairman of Management Board and Chief Executive Officer
Morphosys AG
€751.2K
Charles G. Marianik Chairman of the Board, Chief Executive Officer and President
Horiba Scientific
$219.0K
David L. Hallal Chief Executive Officer and Director
Alexion Pharmaceuticals, Inc.
$696.1K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTREXON CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.